Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | RXRA | P19793 | 1/20 | 0.57 |
| ▸ | RXRB | P28702 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 2/20 | 0.50 |
| ▸ | CHKA | P35790 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1959838 | 0.92 | RXRA (0.59) | ALOX5RXRARXRBTAAR1ESR2 | |
| SCHEMBL817554 | 0.91 | ALOX5 (0.65) | ALOX5TAAR1ESR2MAOBTSHR | |
| SCHEMBL31222672 | 0.91 | ALOX5 (0.65) | ALOX5TAAR1ESR2MAOBTSHR | |
| SCHEMBL29629014 | 0.88 | ALOX5 (0.62) | ALOX5TAAR1ESR2MAOBTSHR | |
| Hydrochloric Acid SCHEMBL31070804 | 0.88 | ALOX5 (0.62) | ALOX5TAAR1ESR2MAOBTSHR | |
| Hydrochloric Acid SCHEMBL28332867 | 0.88 | ALOX5 (0.62) | ALOX5TAAR1ESR2MAOBTSHR | |
| SCHEMBL16394285 | 0.86 | TAAR1 (0.71) | ALOX5TAAR1ESR2MAOBBACE1 | |
| SCHEMBL31491189 | 0.86 | TAAR1 (0.71) | ALOX5TAAR1ESR2MAOBBACE1 | |
| SCHEMBL16939637 | 0.84 | TAAR1 (0.57) | ALOX5RXRARXRBTAAR1ESR2 | |
| SCHEMBL18134355 | 0.84 | TAAR1 (0.57) | ALOX5RXRARXRBTAAR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | claimed |
| US-20260131305-A1 | MANUFACTURE OF BASALT FIBER SORBENT BOOM | GAMBLE VALERIE ANN (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260131304-A1 | BASALT FIBER SORBENT BOOM | GAMBLE VALERIE ANN (US) | 2026-05-14 | — | — | US | disclosed |
| US-12391580-B2 | Use of basalt for adsorbing toxic material | BELL, TOMARO | 2025-08-19 | — | — | US | disclosed |
| US-12391579-B2 | Basalt fiber for adsorbing toxic material | BELL, TOMARO | 2025-08-19 | — | — | US | disclosed |
| US-12384696-B2 | Use of basalt fiber to adsorb toxic material | BELL, TOMARO | 2025-08-12 | — | — | US | disclosed |
| CN-117338229-B | Wireless charging video laryngoscope | 深圳天科医疗科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20240415981-A1 | GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION | CRISPR THERAPEUTICS AG (CH) | 2024-12-19 | — | — | US | disclosed |
| US-20240308879-A1 | USE OF BASALT FOR ADSORBING TOXIC MATERIAL | BELL, TOMARO | 2024-09-19 | — | — | US | disclosed |
| US-20240294399-A1 | USE OF BASALT FIBER TO ADSORB TOXIC MATERIAL | BELL, TOMARO | 2024-09-05 | — | — | US | disclosed |
| US-20230032504-A1 | TREATMENT AND REGENERATION SYSTEM AND METHOD FOR EXTRACTING ORGANIC SOLUTES FROM-WATER | ABS MATERIALS, INC. | 2023-02-02 | — | — | US | disclosed |
| US-11529427-B2 | Gene editing for hemophilia A with improved factor VIII expression | CRISPR THERAPEUTICS AG (CH) | 2022-12-20 | — | — | US | disclosed |
| CN-217790036-U | Multi-module sheet metal case | 青岛艾诺智能仪器有限公司 | 2022-11-11 | — | — | CN | disclosed |
| US-11471859-B2 | Treatment and regeneration system and method for extracting organic solutes from-water | ABS MATERIALS, INC. (US) | 2022-10-18 | — | — | US | disclosed |
| CN-111294708-B | Earphone with ANC feedback microphone arranged behind speaker diaphragm | GN 奥迪欧有限公司 | 2022-09-09 | — | — | CN | disclosed |
| US-20220259509-A1 | SYSTEMS AND METHODS FOR GASIFICATION OF CARBONACEOUS MATERIALS | LLT International (Ireland) Ltd. (IE) | 2022-08-18 | — | — | US | disclosed |
| CN-216693192-U | Wireless chargeable type floor lamp | 东莞市盛祺照明科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| EP-3881907-A1 | METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION | Université de Lille (FR) | 2021-09-22 | — | — | EP | disclosed |
| US-20090269857-A1 | Instruments for detecting low-molecular weight substance | FUJIKURA KASEI CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| EP-1489420-A1 | INSTRUMENTS FOR DETECTING LOW-MOLECULAR WEIGHT SUBSTANCE | Enbiotec Laboratories Co., Ltd. (JP) | 2004-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260131305-A1 | MANUFACTURE OF BASALT FIBER SORBENT BOOM | ABCB11, MAPT, STRA6 | ALOX5 4357/4885RXRA 1720/4885RXRB 1913/4885 |
| US-20260131304-A1 | BASALT FIBER SORBENT BOOM | ABCB11, MAPT, SULT1A1 | ALOX5 4628/4885RXRA 2679/4885RXRB 2831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.